IL17A and non-small cell lung carcinoma: Multi-parametric immune phenotyping of peripheral blood primarily showed alterations in the CD4+ T cell compartment, with increased CD4+ TH17 cells, and higher IL-17 levels in NSCLC BM patients compared to healthy individuals.